Unexpected HbA 1c results in the presence of three rare hemoglobin variants
Authors:
- 14 December 2020
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 81 (1) , 59-64
Abstract
Hemoglobin (Hb) variants, characterized by structural abnormalities in the globin chains, are among the most common inherited disorders. It has been shown that Hb variant remains an important cause of erroneous HbA1c results. Thus, it is important to be aware of the extent of the interference of each Hb variant encountered to avoid reporting unreliable results. However, the effects of many types of Hb variants on the measurement of HbA1c remain unclear. Here, we describe three rare Hb variants, Hb J-Tashikuergan [HBA2: c.59 C > A], Hb Pyrgos [HBB: c.251G > A], and Hb Hope [HBB: c.410 G > A], which lead to extremely high values (>25%) determined by Variant II Turbo 2.0. We further investigated their effects on HbA1c measurement by an HPLC system (Bio-Rad D100), a CE system (Sebia Capillarys 3 TERA), a boronate affinity chromatography system (Premier Hb9210), and an immunoassay method (Roche Diagnostics), and found that these Hb variants severely interfered with HbA1c measurement by Variant II Turbo 2.0 and Bio-Rad D100. This study demonstrates that patients with abnormally high HbA1c levels should be highly suspected of carrying Hb variants. When the HbA1c results are considered unreliable, other indicators such as glycated albumin may be a possible alternative to HbA1c in diabetic patients.Keywords
This publication has 27 references indexed in Scilit:
- Interpretation of Hemoglobin A1cValuesJAMA, 2014
- Glycated albumin; clinical usefulnessClinica Chimica Acta, 2014
- Pathology Consultation on HbA1c Methods and InterferencesAmerican Journal of Clinical Pathology, 2014
- Effects of hemoglobin C, D, E, and S traits on measurements of HbA1c by six methodsClinica Chimica Acta, 2012
- Glycated albumin may be a possible alternative to hemoglobin A1c in diabetic patients with anemiaClinical Chemistry and Laboratory Medicine (CCLM), 2011
- Translating the A1C Assay Into Estimated Average Glucose ValuesDiabetes Care, 2008
- Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studiesNucleic Acids Research, 2004
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- A new fast-moving Hemoglobin Variant, HB J-Tashikuergan α19(Ab1) Ala→GluHemoglobin, 1984